PharmaTher partners with KetaMist inventor to seek FDA approval
Tweet Send to a Friend
PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF) announced a collaboration with Curtis W. Cassidy, M.D., the developer of KetaMist, a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


